Innoviva, Inc.
CIK 1080014 · last filed 2023-01-12
Innoviva, Inc. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ARMP, was dated Jan 12, 2023. Across all open-market trades the lifetime net is +$199.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $116.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$116.86M
2
9
$199.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARMP | Director | 25,076,769 | $4.66 | $116.86M | $140.01M | 5 | 2023-01-12 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | 10%+ Owner | 28,672,897 | $2.19 | $62.79M | $59.12M | 4 | 2022-02-23 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-12 | ARMP | Buy (P) | — | $0 | EDGAR |
| 2022-04-01 | ARMP | Buy (P) | +10,770,416 | $53.85M | EDGAR |
| 2022-02-23 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Other (J) | — | $0 | EDGAR |
| 2022-02-11 | ARMP | Buy (P) | +7,229,584 | $36.15M | EDGAR |
| 2021-05-20 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Buy (P) | +7,462,050 | $14.92M | EDGAR |
| 2021-03-17 | ARMP | Buy (P) | +8,571,870 | $27.86M | EDGAR |
| 2020-09-01 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Buy (P) | +4,672,897 | $12.50M | EDGAR |
| 2020-06-12 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Buy (P) | +12,677,490 | $31.69M | EDGAR |
| 2020-03-31 | ARMP | Buy (P) | +7,717,661 | $22.15M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.